CD28 and Autoimmunity: Studies have suggested that CD28 may play a role following T cell priming, for example blocking CD28 ligands during an ongoing immune response can impair the germinal center response (Han et al., 1995), prolong graft survival, and suppress autoimmunity (Salomon and Bluestone, 2001).